Overview

  • Product name
    Anti-IPO 38 antibody [IPO-38]
    See all IPO 38 primary antibodies
  • Description
    Mouse monoclonal [IPO-38] to IPO 38
  • Tested applications
    Suitable for: ELISA, IHC-P, IHC-Fr, IP, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    A BALB/c mouse was immunized with spleen cells of a human patient with hairy cell leukemia.

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage buffer
    pH: 7.20
    Preservative: 0.01% Sodium azide
    Constituents: 0.42% Potassium phosphate, 2.92% Sodium chloride
  • Concentration information loading...
  • Purity
    Protein A purified
  • Purification notes
    This protein A purified mouse monoclonal antibody reacts with a 14 -16 kDa protein as demonstrated by western blot analysis on the Raji cell line. This antigen was detected after 12 h of PHA-induced activation in the early G1 phase but absent in non-stimulated lymphocytes. Cross reactivity is likely to occur with mouse and rat. Reactivity with other sources has not been determined.
  • Clonality
    Monoclonal
  • Clone number
    IPO-38
  • Isotype
    IgM
  • Light chain type
    kappa
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab1045 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA 1/1000.
IHC-P 1/50 - 1/100.
IHC-Fr Use at an assay dependent dilution.
IP Use at an assay dependent dilution.
WB 1/50 - 1/100.

Target

  • Relevance
    IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin's disease and non-Hodgkin's lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 can be a useful marker of cell proliferation during monitoring of tumor progression.

References for Anti-IPO 38 antibody [IPO-38] (ab1045)

This product has been referenced in:
  • Mikhalap SV  et al. Monoclonal antibody IPO-38 recognizes a novel nuclear antigen of proliferating cells. In Leucocyte Typing VI edited by Kishimoto T et al. Garland Publishing, Inc. New York & London. :609-610 (1997). Read more (PubMed: ) »
  • Sidorenko SP  et al. [Monoclonal antibodies of the IPO series in studying and diagnosing malignant lymphoproliferative diseases] Gematol Transfuziol 35:19-22 (1990). Read more (PubMed: 2373343) »

See all 2 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab1045.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up